Differing from bulk cancer cells, this liver cancer stem cell subpopulation displays resistance to traditional chemotherapeutic drugs via overexpression of the ATP-binding cassette transporters (i.e., ABCB1, ABCG2, and ABCC1), which serve as pumps to actively expel small molecular drugs [2]. Here, ABCG2 is linked to cancer.